quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:22:40·17d
SECFiling
NeoGenomics Inc. logo

SEC Form DEF 14A filed by NeoGenomics Inc.

NEO· NeoGenomics Inc.
Health Care
Original source

Companies

  • NEO
    NeoGenomics Inc.
    Health Care

Recent analyst ratings

  • Jul 30UpdateBTIG Research-
  • Jul 29UpdateWilliam Blair-
  • May 15UpdateGuggenheim-
  • Apr 30UpdateLeerink Partners$9.00
  • Jan 13UpdateThe Benchmark Company-
  • Dec 10UpdateJefferies$22.00

Related

  • PR23h
    NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
  • PR10d
    NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
  • PR16d
    NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
  • SEC17d
    SEC Form DEFA14A filed by NeoGenomics Inc.
  • INSIDER20d
    SEC Form 4 filed by Stone Warren
  • INSIDER20d
    SEC Form 4 filed by Zook Anthony P.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by NeoGenomics Inc.
  • PR38d
    NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022